- Industry
- Health and life sciences
- Organization
- Sartorius Stedim BioOutsource
- Elad’s role
- Built and led technical services teams
The business need
Sartorius Stedim BioOutsource earns revenue from commercial assays, and its in-house functional testing has to comply with GxP and ICH requirements. The technical services teams Elad built had to grow the first while expanding the second.
What Elad did
- Built technical services teams at Sartorius Stedim BioOutsource.
- Led those teams while growing commercial assay revenue.
- Doubled in-house GxP/ICH-compliant functional testing capacity.
Outcome
- In-house GxP/ICH-compliant functional testing capacity doubled.
- Commercial assay revenue grew.
Decisions this experience speaks to
- We're building a drug discovery or disease-modelling platform and aren't sure it's compatible with how pharma and biotech customers actually run their screening workflows - how do we find out?
- We have promising preclinical data, but we don't know if it's strong enough, or the right kind of evidence, to support a partnership or licensing conversation?
Related services and use cases
Sources
This case describes Elad Katz’s own work before Grand Rounds, as Elad’s profile and the public sources above describe it. It is not a Grand Rounds engagement and not a promise of the same result for another company.